These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 1171487)
1. Pharmacological evidence for cerebral dopamine receptor blockade by metoclopramide in rodents. Dolphin A; Jenner P; Marsden CD; Pycock C; Tarsy D Psychopharmacologia; 1975; 41(2):133-8. PubMed ID: 1171487 [TBL] [Abstract][Full Text] [Related]
2. Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA. Johnson AM; Loew DM; Vigouret JM Br J Pharmacol; 1976 Jan; 56(1):59-68. PubMed ID: 943193 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of circling behavior by neuroleptic drugs in mice with unilateral 6-hydroxydopamine lesions of the striatum. Pycock C; Tarsy D; Marsden CD Psychopharmacologia; 1975 Dec; 45(2):211-9. PubMed ID: 1240638 [TBL] [Abstract][Full Text] [Related]
4. Relation between motor asymmetry and direction of rotational behaviour under amphetamine and apomorphine in rats with unilateral degeneration of the nigrostriatal dopamine system. Ziegler MG; Szechtman H Behav Brain Res; 1990 Jul; 39(2):123-33. PubMed ID: 2390196 [TBL] [Abstract][Full Text] [Related]
5. The effect of chronic L-dopa treatment on the recovery of motor function in 6-hydroxydopamine-lesioned rats receiving ventral mesencephalic grafts. Blunt S; Jenner P; Marsden CD Neuroscience; 1991; 40(2):453-64. PubMed ID: 1902916 [TBL] [Abstract][Full Text] [Related]
7. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment. Hinzen D; Hornykiewicz O; Kobinger W; Pichler L; Pifl C; Schingnitz G Eur J Pharmacol; 1986 Nov; 131(1):75-86. PubMed ID: 3816949 [TBL] [Abstract][Full Text] [Related]
8. Caffeine produces contralateral rotation in rats with unilateral dopamine denervation: comparisons with apomorphine-induced responses. Herrera-Marschitz M; Casas M; Ungerstedt U Psychopharmacology (Berl); 1988; 94(1):38-45. PubMed ID: 3126526 [TBL] [Abstract][Full Text] [Related]
9. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus. Donaldson I; Dolphin A; Jenner P; Marsden CD; Pycock C Eur J Pharmacol; 1976 Oct; 39(2):179-91. PubMed ID: 976315 [TBL] [Abstract][Full Text] [Related]
11. Potentiation of apomorphine-induced stereotyped behaviour by acute treatment with dopamine depleting agents: a potential role for an increased stimulation of D1 dopamine receptors. Vasse M; Protais P Neuropharmacology; 1989 Sep; 28(9):931-9. PubMed ID: 2554186 [TBL] [Abstract][Full Text] [Related]
12. Effects of chronic morphine treatment on dopamine-mediated turning behaviour in rats and mice with 6-hydroxydopamine-induced unilateral nigro-striatal lesions. Slater P; Crossman AR Neuropharmacology; 1980 Mar; 19(3):289-95. PubMed ID: 7191487 [No Abstract] [Full Text] [Related]
13. Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function. Jerussi TP; Glick SD Psychopharmacology (Berl); 1976 Jun; 47(3):249-60. PubMed ID: 823560 [TBL] [Abstract][Full Text] [Related]
14. Behavioral demonstration of a reciprocal interaction between dopamine receptor subtypes in the mouse striatum: possible involvement of the striato-nigral pathway. Mandel RJ; Yurek DM; Randall PK Brain Res Bull; 1990 Aug; 25(2):285-92. PubMed ID: 2146002 [TBL] [Abstract][Full Text] [Related]
15. Circling behavior in rats with partial, unilateral nigro-striatal lesions: effect of amphetamine, apomorphine, and DOPA. Hefti F; Melamed E; Sahakian BJ; Wurtman RJ Pharmacol Biochem Behav; 1980 Feb; 12(2):185-8. PubMed ID: 7189592 [TBL] [Abstract][Full Text] [Related]
16. Rotational behavior induced by unilateral electrical stimulations of nigro-striatal dopamine neurons: modification by low doses of apomorphine. Barghon R; Costentin JH Eur J Pharmacol; 1980 May; 64(1):39-46. PubMed ID: 6969658 [TBL] [Abstract][Full Text] [Related]
17. The relative importance of dopamine and noradrenaline receptor stimulation for the restoration of motor activity in reserpine or alpha-methyl-p-tyrosine pre-treated mice. Dolphin AC; Jenner P; Marsden CD Pharmacol Biochem Behav; 1976 Jun; 4(6):661-70. PubMed ID: 981283 [TBL] [Abstract][Full Text] [Related]
18. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system. Pycock C; Milson J; Tarsy D; Marsden CD Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479 [No Abstract] [Full Text] [Related]
19. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide. Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008 [TBL] [Abstract][Full Text] [Related]
20. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist. Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]